» Articles » PMID: 33092114

Contribution of MiRNAs, TRNAs and TRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Oct 23
PMID 33092114
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Transcriptomics profiles of miRNAs, tRNAs or tRFs are used as biomarkers, after separate examination of several cancer cell lines, blood samples or biopsies. However, the possible contribution of all three profiles on oncogenic signaling and translation as a net regulatory effect, is under investigation. The present analysis of miRNAs and tRFs from lung cancer biopsies indicated putative targets, which belong to gene networks involved in cell proliferation, transcription and translation regulation. In addition, we observed differential expression of specific tRNAs along with several tRNA-related genes with possible involvement in carcinogenesis. Transfection of lung adenocarcinoma cells with two identified tRFs and subsequent NGS analysis indicated gene targets that mediate signaling and translation regulation. Broader analysis of all major signaling and translation factors in several biopsy specimens revealed a crosstalk between the PI3K/AKT and MAPK pathways and downstream activation of eIF4E and eEF2. Subsequent polysome profile analysis and 48S pre-initiation reconstitution experiments showed increased global translation rates and indicated that aberrant expression patterns of translation initiation factors could contribute to elevated protein synthesis. Overall, our results outline the modulatory effects that possibly correlate the expression of important regulatory non-coding RNAs with aberrant signaling and translation deregulation in lung cancer.

Citing Articles

High Intratumoral i-tRF-Gly Expression Predicts Short-Term Relapse and Poor Overall Survival of Colorectal Cancer Patients, Independent of the TNM Stage.

Christodoulou S, Katsaraki K, Vassiliu P, Danias N, Michalopoulos N, Tzikos G Biomedicines. 2023; 11(7).

PMID: 37509584 PMC: 10377136. DOI: 10.3390/biomedicines11071945.


Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation.

Kobayashi A, Takeiwa T, Ikeda K, Inoue S Int J Mol Sci. 2023; 24(11).

PMID: 37298366 PMC: 10253563. DOI: 10.3390/ijms24119414.


A Novel Prognostic Model Based on Seven Necroptosis-Related miRNAs for Predicting the Overall Survival of Patients with Lung Adenocarcinoma.

Hong X, Wang G, Pei K, Mo C, Rong Z, Xu G Biomed Res Int. 2022; 2022:3198590.

PMID: 35372581 PMC: 8972154. DOI: 10.1155/2022/3198590.


Mitochondrial tRNA-Derived Fragments and Their Contribution to Gene Expression Regulation.

Shaukat A, Kaliatsi E, Stamatopoulou V, Stathopoulos C Front Physiol. 2021; 12:729452.

PMID: 34539450 PMC: 8446549. DOI: 10.3389/fphys.2021.729452.

References
1.
Goodarzi H, Liu X, Nguyen H, Zhang S, Fish L, Tavazoie S . Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement. Cell. 2015; 161(4):790-802. PMC: 4457382. DOI: 10.1016/j.cell.2015.02.053. View

2.
Zhang Z, Ye Y, Gong J, Ruan H, Liu C, Xiang Y . Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers. Commun Biol. 2018; 1:234. PMC: 6303286. DOI: 10.1038/s42003-018-0239-8. View

3.
Kumar P, Kuscu C, Dutta A . Biogenesis and Function of Transfer RNA-Related Fragments (tRFs). Trends Biochem Sci. 2016; 41(8):679-689. PMC: 5173347. DOI: 10.1016/j.tibs.2016.05.004. View

4.
Bracken C, Scott H, Goodall G . A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016; 17(12):719-732. DOI: 10.1038/nrg.2016.134. View

5.
Schimmel P . The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat Rev Mol Cell Biol. 2017; 19(1):45-58. DOI: 10.1038/nrm.2017.77. View